FDA employees consider how to handle RFK Jr., including leaving
Some staff members at the Food and Drug Administration are considering a quick exit as
Robert F. Kennedy Jr. is being floated as a potential health official
in the incoming Trump administration, according to three former and one current government official who were granted anonymity to speak freely about sensitive issues. The former officials are still in touch with colleagues who work at the FDA.
Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered leaving before President-elect Donald Trump’s first term in office, said one former and one current official. At the time, there were also concerns about what the FDA would look like under the first Trump administration.
But there ended up being “relatively lit...